Wine Antioxidants and Their Impact on Antioxidant Activity in Vivo

ACS Symposium Series

Volumn 661, Issue , 1997, Pages 150-165

  Maxwell, Simon R J ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0011124568     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: 10.1021/bk-1997-0661.ch012     Document Type: Article

References (57)

1. Halliwell, B.; Gutteridge, J.M.C. Free Radicals in Biology and Medicine; 2nd Edition; Clarendon Press: Oxford, UK, 1989.
2. Steinberg, D.; Parthasarathy, S.; Carew, T.; Khoo, J.; Witztum, J. Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity. New England Journal of Medicine 1989, 320, 915-924.
3. Goldstein, J.L; Brown, M.S. The low-density lipoprotein pathway and its relation to atherosclerosis. Annual Review of Biochemistry 1977, 46, 897-930.
4. Quinn, M.T.; Parathasarathy, S.; Fong, L.G.; Steinberg, D. Oxidatively modified low-density lipoprotein : a potential role in recruitment and retention of monocyte- macrophages during atherogenesis. Proceedings of the National Academy of Science USA 1987, 664, 2995-2998.
5. Hessler, J.R.; Robertson, A.L.; Chrisholm, G.M. Low-density lipoprotein- induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979, 32, 213-229.
6. Ross, R. Pathogenesis of atherosclerosis : a perspective for the 1990s. Nature 1993, 362, 801-809.
7. Riemersma, R.A.; Wood, D.A.; MacIntyre, C.C.; Elton, R.; Gey, K.F.; Oliver, M.F. Risk of angina pectoris and plasma concentrations of vitamins A,C, E and carotene. Lancet 1991, 337, 1-5.
8. Rimm, E.B.; Stampfer, M.J.; Ascherio, A.; Giovannucci, E.; Colditz, G.A.; Willett, W.C. Vitamin E consumption and the risk of coronary heart disease in men. New England Journal of Medicine 1993, 328, 1450-1456.
9. Stampfer, M.J.; Hennekens, C.H.; Manson, J.E.; Colditz, G.A.; Rosner, B.; Willett, W.C. Vitamin E consumption and risk of coronary disease in women. New England Journal of Medicine 1993, 328, 1444-1449.
10. Hertog, M.G.; Feskens, E.J.M.; Hollman, P.C.H.; Katan, M.B.; Kromhout, D. Dietary antioxidant flavonoids and risk of coronary artery disease : the Zutphen Elderly Study. Lancet 1993, 342, 1007-1011.
11. Hertog, M.G.L.; Kromhout, D.; Aravanis, C.; Blackburn, H.; Buzina, R.; Fidanza, F. et al. Flavonoids intake and long-term risk of cornary heart disease and cancer in the seven countries study. Archives of Internal Medicine 1995, 155, 381-386.
12. Knekt, P.; Jarvinen, R.; Reunanen, A.; Maatela, J. Flavonoid intake and coronary mortality in Finland : a cohort study. British Medical Journal 1996, 312, 478-481.
13. Waterhouse, A.L.; Frankel, E.N. Proceedings OIV 73rd General Assembly, San Francisco, August 29-September 3, 1993; OIV: Paris, France, 1993; Wine antioxidants may reduce heart disease and cancer, pp. 1-15.
14. Rimm, E.B.; Giovannucci, E.L.; Willett, W.C. et al. Prospective study of alcohol consumption and risk of coronary artery disease in men. Lancet 1991, 338, 464-486.
15. Hein, H.O.; Suadicani, P.; Gyntelberg, F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease : six year follow up in the Copenhagen male study. British Medical Journal 1996, 312, 736-741.
16. Lazarus, N.B.; Kaplan, G.A.; Cohen, R.D.; Diing-Jen, L. Change in alcohol consumption and risk of death from all causes and from ischaemic heart disease. British Medical Journal 1991, 303, 553-556.
17. Friedman, L.A.; Kimball, A.W. Coronary artery disease mortality and alcohol consumption in Framingham. American Journal of Epidemiology 1986, 24, 481-48.
18. Renaud, S.; de Lorgeril, M. Wine, alcohol, platelets, and the French paradox for coronary artery disease. Lancet 1992, 339, 1523-1526.
19. Klurfeld, D.M.; Kritchevsky, D. Differential effects of alcoholic beverages on experimental atherosclerosis in rabbits. Experimental Molecular Pathology 1981, 34, 62-71.
20. Rimm, E.B.; Klatsky, A.; Grobbee, D.; Stampfer, M.J. Review of moderate alcohol consumption and reduced risk of coronary heart disease : is the effect due to wine, beer or spirits? British Medical Journal 1996, 312, 731-736.
21. St Leger, A.S.; Cochrane, A.L.; Moore, F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979, i, 1017-1020.
22. Halliwell, B. Antioxidants in wine. Lancet 1993, 341, 1538.
23. Troup, G.J.; Hutton, D.R.; Hewitt, D.G.; Hunter, C.R. Free radicals in red wine, but not in white? Free Radical Research 1994, 20, 63-68.
24. Laughton, M.J.; Halliwell, B.; Evans, P.J.; Hoult, J.R. Antioxidant and prooxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation, and bleomycin-dependent damage to DNA. Biochemical Pharmacology 1989, 38, 2849-2865.
25. Husain, S.R.; Cillard, J.; Cillard, P. Hydroxyl radical scavenging activity of flavonoids. Phytochemisiry 1987, 26, 2489-2491.
26. Robak, J.; Gryglewski, R.J. Flavonoids are scavengers of superoxide anion. Biochemical Pharmacology 1988, 37, 83-88.
27. Yuting, C.; Rongliang, Z.; Zhongjian, J.; Yong, J. Flavonoids as superoxide scavengers and antioxidants. Free Radicals in Biology and Medicine 1990, 9, 19-21.
28. Hanasaki, Y.; Ogawa, S.; Fukui, S. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radicals in Biology and Medicine 1994, 16, 845-850.
29. Torel, J.; Cillard, J.; Cillard, P. Antioxidant activity of flavonoids and reactivity with peroxyl radicals. Phytochemistry 1986, 25, 383-385.
30. Cotelle, N.; Bernier, J.L.; Henichart, J..P; Catteau, J.P. Free Radicals in Biology and Medicine 1992, 13, 211-219.
31. Morel, I.; Lescoat, G.; Cillard, P.; Cillard, J. Role of flavonoids and iron chelation in antioxidant action. Methods in Enzymology 1994, 234, 437-443.
32. Afanaslev, I.B.; Dorozhko, A.I.; Brodskii, A.V. et al. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochemical Pharmacology 1989, 38, 1763-1769.
33. Mangipane, H.; Thomson, J; Salter, A.; Brown, S.; Bell, G.D., White, D.A. The inhibition of the oxidation of low-density lipoprotein by (+)-catechin, a naturally occuring flavonoid. Biochemical Pharmacology 1992, 43, 445-450.
34. de Whalley, C.V.; Rankin, S.M.; Hoult, J.R.S.; Jessup, W.; Leake, D.S. Flavonoids inhibit the oxidative modification of low-density lipoproteins by macrophages. Biochemical Pharmacology 1990, 39, 1743-1750.
35. Jessup, W.; Rankin, S.M.; de Whalley, C; Hoult, J.R.S.; Scott, J.; Leake, D.S. Alpha-tocopherol consumption during low-density lipoprotein oxidation. Biochemical Journal 1990, 265, 399-405.
36. Frankel, E.N.; Kanner, J.; German, G.B.; Parks, E.; Kinsella, J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic sustances in red wine. Lancet 1993, 341, 454-457.
37. Frankel, E.N.; Waterhouse, A.L.; Kinsella, J.E. Inhibition of human LDL oxidation by resveratrol. Lancet 1993, 341, 1103-1104.
38. Negre-Salvayre, A.; Salvayre, R. Quercetin prevents the cytotoxicity of oxidized low density lipoproteins in lymphoid cell lines. Free Radicals in Biology and Medicine 1992, 12, 101-106.
39. Laughton, M.J.; Evans, P.J.; Moroney, M.A.; Hoult, J.R.S.; Halliwell, B. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives : relationship to antioxidant activity and iron ion-reducing ability. Biochemical Pharmacology 1991, 42, 1673-1681.
40. Moroney, M.-A.; Alcaraz, M.J.; Forder, R.A. et al. Selectivity of 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. Journal of Pharmacy and Pharmacology 1988, 40, 787-792.
41. Takahama, U. Inhibition of lipoxygenase-dependent lipid peroxidation by quercetin : mechanism of antioxidative function. Phytochemistry 1985, 24, 1443-1446.
42. Busse, W.W.; Kopp, D.E.; Middleton, E. Flavonoid modulation of human neutrophil function. Journal of Allergy and Clinical Immunology 1984, 73, 810.
43. Hodnick, W.F.; Kung, F.S.; Roettger, W.J.; Bohmont, C.W.; Pardini, R.S. Inhibition of mitochondrial respiration and production of toxic oxygen radicals by flavonoids - a structure-activity study. Biochemical Pharmacology 1986, 35, 2345-2357.
44. Corvazier, E.; Maclouf, J. Interference of some flavonoids and non-steroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. Biochimica et Biophysica Acta 1985, 835, 315-321.
45. Muldoon, M.F., Kritchevsky, S.B. Flavonoids and heart disease. British Medical Journal 1996, 312, 458-459.
46. Whitehead, T.P.; Thorpe, G.H.G., Maxwell, S.R.J. An enhanced chemiluminescent assay for antioxidant capacity in biological fluids. Analytica Chimica Acta 1992, 266, 265-277.
47. Maxwell, S.R.J.; Cruickshank, A.; Thorpe, G.H.G. Red wine and antioxidant activity in serum. Lancet 1994, 334, 193-194.
48. Whitehead, T.P.; Robinson, D.; Allaway, S.; Syms, J.; Hale, A. The effect of red wine ingestion on the antioxidant capacity of serum. Clinical Chemistry 1995, 41, 32-35.
49. Wayner, D.D.M.; Burton, G.W.; Ingold, K.U.; Barclay, L.R.C.; Locke, S.J. The relative contributions of Vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochimica et Biophysica Acta 1987, 924, 408-419.
50. Day, A.; Stansbie, D. Cardioprotective effect of red wine may be mediated by urate. Clinical Chemistry 1995, 41, pp.
51. Becker, B.F. Towards the physiological function of uric acid. Free Radicals in Biology and Medicine 1993, 14, 615-631.
52. Davies, K.J.A.; Sevanian, A.; Muakkassah-Kelly, S.F.; Hochstein, P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochemical Journal 1986, 235, 747-754.
53. Frei, B.; Stocker, R.; Ames, B.N. Antioxidant defences and lipid peroxidation in human blood plasma. Proceeding of the National Academy of Science USA 1988, 85, 9748-9752.
54. Das, N.P. Studies on flavonoid metabolism : absorption and metabolism of (+)-catechin in man. Biochemical Pharmacology 1971, 20, 3435-3445.
55. Gugler, R.; Leschik, M.; Dengler, H.J. Deposition of quercetin in man after single oral and intravenous doses. European Journal of Clinical Pharmacology 1975, 9, 229-234.
56. Fuhrman, B.; Lavy, A.; Aviram, M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. American Journal of Clinical Nutrition 1995, 61, 549-554.
57. Goldberg, D.M. Does wine work? Clinical Chemistry 1995, 41, 14-16.